 | • レポートコード：B-GIR09F2904 • 出版社/出版日：GlobalInfoResearch / 2019年9月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ダルナビルの世界市場について調べ、まとめました。種類別セグメントは、タブレット、経口懸濁液等、用途別セグメントは、病院、薬局等に区分しました。ダルナビルの世界市場概観、企業動向、企業別ダルナビルシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ダルナビルの市場概観 ・ダルナビルの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ダルナビルの企業別販売動向、市場シェア、市場集中度、競争動向 ・ダルナビルの世界市場規模 ・ダルナビルの北米市場分析（アメリカ、カナダ、メキシコ等） ・ダルナビルのアメリカ市場規模推移 ・ダルナビルのカナダ市場規模推移 ・ダルナビルのメキシコ市場規模推移 ・ダルナビルのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ダルナビルのドイツ市場規模推移 ・ダルナビルのイギリス市場規模推移 ・ダルナビルのロシア市場規模推移 ・ダルナビルのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ダルナビルの日本市場規模推移 ・ダルナビルの中国市場規模推移 ・ダルナビルの韓国市場規模推移 ・ダルナビルのインド市場規模推移 ・ダルナビルの東南アジア市場規模推移 ・ダルナビルの南米市場分析（ブラジル、アルゼンチン等） ・ダルナビルの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ダルナビルの種類別分析/販売量、売上、市場シェア（タブレット、経口懸濁液） ・ダルナビルの用途別分析/市場規模（病院、薬局） ・ダルナビルの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ダルナビルの販売チャネル・代理店・貿易業者・ディーラー分析 |
Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
Scope of the Report:
The global Darunavir market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Darunavir.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Darunavir market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Darunavir market by product type and applications/end industries.
Market Segment by Companies, this report covers
Janssen Therapeutics
Mylan
Teva
Cipla
Lupin
Hetero
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablet
Oral suspension
Market Segment by Applications, can be divided into
Hospital
Drug store
Table of Contents
1 Darunavir Market Overview
1.1 Product Overview and Scope of Darunavir
1.2 Classification of Darunavir by Types
1.2.1 Global Darunavir Revenue Comparison by Types (2019-2024)
1.2.2 Global Darunavir Revenue Market Share by Types in 2018
1.2.3 Tablet
1.2.4 Oral suspension
1.3 Global Darunavir Market by Application
1.3.1 Global Darunavir Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Darunavir Market by Regions
1.4.1 Global Darunavir Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Darunavir Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Darunavir Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Darunavir Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Darunavir Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Darunavir Status and Prospect (2014-2024)
1.5 Global Market Size of Darunavir (2014-2024)
2 Manufacturers Profiles
2.1 Janssen Therapeutics
2.1.1 Business Overview
2.1.2 Darunavir Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Janssen Therapeutics Darunavir Revenue, Gross Margin and Market Share (2017-2018)
2.2 Mylan
2.2.1 Business Overview
2.2.2 Darunavir Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mylan Darunavir Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva
2.3.1 Business Overview
2.3.2 Darunavir Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Darunavir Revenue, Gross Margin and Market Share (2017-2018)
2.4 Cipla
2.4.1 Business Overview
2.4.2 Darunavir Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cipla Darunavir Revenue, Gross Margin and Market Share (2017-2018)
2.5 Lupin
2.5.1 Business Overview
2.5.2 Darunavir Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Lupin Darunavir Revenue, Gross Margin and Market Share (2017-2018)
2.6 Hetero
2.6.1 Business Overview
2.6.2 Darunavir Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Hetero Darunavir Revenue, Gross Margin and Market Share (2017-2018)
3 Global Darunavir Market Competition, by Players
3.1 Global Darunavir Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Darunavir Players Market Share
3.2.2 Top 10 Darunavir Players Market Share
3.3 Market Competition Trend
4 Global Darunavir Market Size by Regions
4.1 Global Darunavir Revenue and Market Share by Regions
4.2 North America Darunavir Revenue and Growth Rate (2014-2019)
4.3 Europe Darunavir Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Darunavir Revenue and Growth Rate (2014-2019)
4.5 South America Darunavir Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Darunavir Revenue and Growth Rate (2014-2019)
5 North America Darunavir Revenue by Countries
5.1 North America Darunavir Revenue by Countries (2014-2019)
5.2 USA Darunavir Revenue and Growth Rate (2014-2019)
5.3 Canada Darunavir Revenue and Growth Rate (2014-2019)
5.4 Mexico Darunavir Revenue and Growth Rate (2014-2019)
6 Europe Darunavir Revenue by Countries
6.1 Europe Darunavir Revenue by Countries (2014-2019)
6.2 Germany Darunavir Revenue and Growth Rate (2014-2019)
6.3 UK Darunavir Revenue and Growth Rate (2014-2019)
6.4 France Darunavir Revenue and Growth Rate (2014-2019)
6.5 Russia Darunavir Revenue and Growth Rate (2014-2019)
6.6 Italy Darunavir Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Darunavir Revenue by Countries
7.1 Asia-Pacific Darunavir Revenue by Countries (2014-2019)
7.2 China Darunavir Revenue and Growth Rate (2014-2019)
7.3 Japan Darunavir Revenue and Growth Rate (2014-2019)
7.4 Korea Darunavir Revenue and Growth Rate (2014-2019)
7.5 India Darunavir Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Darunavir Revenue and Growth Rate (2014-2019)
8 South America Darunavir Revenue by Countries
8.1 South America Darunavir Revenue by Countries (2014-2019)
8.2 Brazil Darunavir Revenue and Growth Rate (2014-2019)
8.3 Argentina Darunavir Revenue and Growth Rate (2014-2019)
8.4 Colombia Darunavir Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Darunavir by Countries
9.1 Middle East and Africa Darunavir Revenue by Countries (2014-2019)
9.2 Saudi Arabia Darunavir Revenue and Growth Rate (2014-2019)
9.3 UAE Darunavir Revenue and Growth Rate (2014-2019)
9.4 Egypt Darunavir Revenue and Growth Rate (2014-2019)
9.5 Nigeria Darunavir Revenue and Growth Rate (2014-2019)
9.6 South Africa Darunavir Revenue and Growth Rate (2014-2019)
10 Global Darunavir Market Segment by Type
10.1 Global Darunavir Revenue and Market Share by Type (2014-2019)
10.2 Global Darunavir Market Forecast by Type (2019-2024)
10.3 Tablet Revenue Growth Rate (2014-2024)
10.4 Oral suspension Revenue Growth Rate (2014-2024)
11 Global Darunavir Market Segment by Application
11.1 Global Darunavir Revenue Market Share by Application (2014-2019)
11.2 Darunavir Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Drug store Revenue Growth (2014-2019)
12 Global Darunavir Market Size Forecast (2019-2024)
12.1 Global Darunavir Market Size Forecast (2019-2024)
12.2 Global Darunavir Market Forecast by Regions (2019-2024)
12.3 North America Darunavir Revenue Market Forecast (2019-2024)
12.4 Europe Darunavir Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Darunavir Revenue Market Forecast (2019-2024)
12.6 South America Darunavir Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Darunavir Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Darunavir Picture
Table Product Specifications of Darunavir
Table Global Darunavir and Revenue (Million USD) Market Split by Product Type
Figure Global Darunavir Revenue Market Share by Types in 2018
Figure Tablet Picture
Figure Oral suspension Picture
Table Global Darunavir Revenue (Million USD) by Application (2014-2024)
Figure Darunavir Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug store Picture
Table Global Market Darunavir Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Darunavir Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Darunavir Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Darunavir Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Darunavir Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Darunavir Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Darunavir Revenue (Million USD) and Growth Rate (2014-2024)
Table Janssen Therapeutics Basic Information, Manufacturing Base and Competitors
Table Janssen Therapeutics Darunavir Type and Applications
Table Janssen Therapeutics Darunavir Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Darunavir Type and Applications
Table Mylan Darunavir Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Darunavir Type and Applications
Table Teva Darunavir Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Darunavir Type and Applications
Table Cipla Darunavir Revenue, Gross Margin and Market Share (2017-2018)
Table Lupin Basic Information, Manufacturing Base and Competitors
Table Lupin Darunavir Type and Applications
Table Lupin Darunavir Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Basic Information, Manufacturing Base and Competitors
Table Hetero Darunavir Type and Applications
Table Hetero Darunavir Revenue, Gross Margin and Market Share (2017-2018)
Table Global Darunavir Revenue (Million USD) by Players (2014-2019)
Table Global Darunavir Revenue Share by Players (2014-2019)
Figure Global Darunavir Revenue Share by Players in 2017
Figure Global Darunavir Revenue Share by Players in 2018
Figure Global Top 5 Players Darunavir Revenue Market Share in 2018
Figure Global Top 10 Players Darunavir Revenue Market Share in 2018
Figure Global Darunavir Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Darunavir Revenue (Million USD) by Regions (2014-2019)
Table Global Darunavir Revenue Market Share by Regions (2014-2019)
Figure Global Darunavir Revenue Market Share by Regions (2014-2019)
Figure Global Darunavir Revenue Market Share by Regions in 2018
Figure North America Darunavir Revenue and Growth Rate (2014-2019)
Figure Europe Darunavir Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Darunavir Revenue and Growth Rate (2014-2019)
Figure South America Darunavir Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Darunavir Revenue and Growth Rate (2014-2019)
Table North America Darunavir Revenue by Countries (2014-2019)
Table North America Darunavir Revenue Market Share by Countries (2014-2019)
Figure North America Darunavir Revenue Market Share by Countries (2014-2019)
Figure North America Darunavir Revenue Market Share by Countries in 2018
Figure USA Darunavir Revenue and Growth Rate (2014-2019)
Figure Canada Darunavir Revenue and Growth Rate (2014-2019)
Figure Mexico Darunavir Revenue and Growth Rate (2014-2019)
Table Europe Darunavir Revenue (Million USD) by Countries (2014-2019)
Figure Europe Darunavir Revenue Market Share by Countries (2014-2019)
Figure Europe Darunavir Revenue Market Share by Countries in 2018
Figure Germany Darunavir Revenue and Growth Rate (2014-2019)
Figure UK Darunavir Revenue and Growth Rate (2014-2019)
Figure France Darunavir Revenue and Growth Rate (2014-2019)
Figure Russia Darunavir Revenue and Growth Rate (2014-2019)
Figure Italy Darunavir Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Darunavir Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Darunavir Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Darunavir Revenue Market Share by Countries in 2018
Figure China Darunavir Revenue and Growth Rate (2014-2019)
Figure Japan Darunavir Revenue and Growth Rate (2014-2019)
Figure Korea Darunavir Revenue and Growth Rate (2014-2019)
Figure India Darunavir Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Darunavir Revenue and Growth Rate (2014-2019)
Table South America Darunavir Revenue by Countries (2014-2019)
Table South America Darunavir Revenue Market Share by Countries (2014-2019)
Figure South America Darunavir Revenue Market Share by Countries (2014-2019)
Figure South America Darunavir Revenue Market Share by Countries in 2018
Figure Brazil Darunavir Revenue and Growth Rate (2014-2019)
Figure Argentina Darunavir Revenue and Growth Rate (2014-2019)
Figure Colombia Darunavir Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Darunavir Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Darunavir Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Darunavir Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Darunavir Revenue Market Share by Countries in 2018
Figure Saudi Arabia Darunavir Revenue and Growth Rate (2014-2019)
Figure UAE Darunavir Revenue and Growth Rate (2014-2019)
Figure Egypt Darunavir Revenue and Growth Rate (2014-2019)
Figure Nigeria Darunavir Revenue and Growth Rate (2014-2019)
Figure South Africa Darunavir Revenue and Growth Rate (2014-2019)
Table Global Darunavir Revenue (Million USD) by Type (2014-2019)
Table Global Darunavir Revenue Share by Type (2014-2019)
Figure Global Darunavir Revenue Share by Type (2014-2019)
Figure Global Darunavir Revenue Share by Type in 2019
Table Global Darunavir Revenue Forecast by Type (2019-2024)
Figure Global Darunavir Market Share Forecast by Type (2019-2024)
Figure Global Tablet Revenue Growth Rate (2014-2019)
Figure Global Oral suspension Revenue Growth Rate (2014-2019)
Table Global Darunavir Revenue by Application (2014-2019)
Table Global Darunavir Revenue Share by Application (2014-2019)
Figure Global Darunavir Revenue Share by Application (2014-2019)
Figure Global Darunavir Revenue Share by Application in 2019
Table Global Darunavir Revenue Forecast by Application (2019-2024)
Figure Global Darunavir Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Drug store Revenue Growth Rate (2014-2019)
Figure Global Darunavir Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Darunavir Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Darunavir Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Darunavir Revenue Market Forecast (2019-2024)
Figure Europe Darunavir Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Darunavir Revenue Market Forecast (2019-2024)
Figure South America Darunavir Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Darunavir Revenue Market Forecast (2019-2024)
世界のアンブリセンタン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Scope of the Report: The global Ambrisentan Drug market is valued at xx million USD in 2018 and is expected to reach xx mil…- 世界のコレセベラム市場予測（～2024年） Colesevelam is a bile acid sequestrant administered orally. Colesevelam is used along with diet, weight loss, and exercise to reduce the amount of cholesterol and certain fatty substances in the blood. Scope of the Report: The global Colesevelam market is valued at xx million USD in 2018 and is expe…
- 世界のシクロベンザプリン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous s…
- 世界のエクセナチド市場予測（～2024年）：企業別、地域別、種類・用途別 Exenatide (marketed as Byetta, Bydureon) is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2. Scope of the Report: The global Exenatide market is valued at…
- 世界のアリスキレン市場予測（～2024年）：企業別、地域別、種類・用途別 Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension. Scope of the Report: The global Aliskiren market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 20…